It mitigates AD risk and suppresses neuroinflammation by downregulating the transcription and expression of genes encoding inducible nitric oxide synthase (iNOS), matrix metalloproteinase-2 (MMP-2), and the transcription factor NF-κBp65 [405]. The gene discussed is MMP2; the disease is Alzheimer disease.